Phase II study of fazarabine in advanced head and neck cancer : a southwest oncology group study
Gespeichert in:
| Veröffentlicht in: | Investigational new drugs 1991-11, Vol.9 (4), p.373-374 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 374 |
|---|---|
| container_issue | 4 |
| container_start_page | 373 |
| container_title | Investigational new drugs |
| container_volume | 9 |
| creator | KUEBLER, J. P METCH, B SCHULLER, D. E KEPPEN, M HYNES, H. E |
| description | |
| doi_str_mv | 10.1007/BF00183585 |
| format | Article |
| fullrecord | <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1007_BF00183585</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1725172</sourcerecordid><originalsourceid>FETCH-LOGICAL-c270t-4bb9f3a05304cf2db77b18d17f0df620dc06b9e61118e0aa5e47bb10df7770ac3</originalsourceid><addsrcrecordid>eNpFkE1Lw0AQhhdRaq1evAtz8CREZ5NstvGmxWqhoAc9x9mvNtomZTdR6q83kmIPw8C8Dy_Mw9g5x2uOKG_up4h8nIixOGBDLmQSYZZmh2yIPJNRlufymJ2E8IGISS7TARtwGYtuhuz9ZUnBwmwGoWnNFmoHjn7IkyorC2UFZL6o0tbA0pIBqgxUVn-C_jt6uAWCULfN8tuGBupK16t6sYWFr9tN33jKjhytgj3b7RF7mz68Tp6i-fPjbHI3j3QssYlSpXKXEIoEU-1io6RUfGy4dGhcFqPRmKncZpzzsUUiYVOpFO9CKSWSTkbsqu_Vvg7BW1dsfLkmvy04Fn-Wir2lDr7o4U2r1tbs0V5Ll1_ucgqaVs5335bhHxPIhehc_gJqjW5u</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Phase II study of fazarabine in advanced head and neck cancer : a southwest oncology group study</title><source>MEDLINE</source><source>SpringerNature Journals</source><creator>KUEBLER, J. P ; METCH, B ; SCHULLER, D. E ; KEPPEN, M ; HYNES, H. E</creator><creatorcontrib>KUEBLER, J. P ; METCH, B ; SCHULLER, D. E ; KEPPEN, M ; HYNES, H. E</creatorcontrib><identifier>ISSN: 0167-6997</identifier><identifier>EISSN: 1573-0646</identifier><identifier>DOI: 10.1007/BF00183585</identifier><identifier>PMID: 1725172</identifier><identifier>CODEN: INNDDK</identifier><language>eng</language><publisher>Dordrecht: Kluwer</publisher><subject>Adult ; Aged ; Antineoplastic agents ; Antineoplastic Agents - therapeutic use ; Azacitidine - adverse effects ; Azacitidine - therapeutic use ; Biological and medical sciences ; Chemotherapy ; Drug Evaluation ; Female ; Head and Neck Neoplasms - drug therapy ; Humans ; Male ; Medical sciences ; Middle Aged ; Pharmacology. Drug treatments</subject><ispartof>Investigational new drugs, 1991-11, Vol.9 (4), p.373-374</ispartof><rights>1992 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c270t-4bb9f3a05304cf2db77b18d17f0df620dc06b9e61118e0aa5e47bb10df7770ac3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,782,786,27931,27932</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=5015500$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1725172$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>KUEBLER, J. P</creatorcontrib><creatorcontrib>METCH, B</creatorcontrib><creatorcontrib>SCHULLER, D. E</creatorcontrib><creatorcontrib>KEPPEN, M</creatorcontrib><creatorcontrib>HYNES, H. E</creatorcontrib><title>Phase II study of fazarabine in advanced head and neck cancer : a southwest oncology group study</title><title>Investigational new drugs</title><addtitle>Invest New Drugs</addtitle><subject>Adult</subject><subject>Aged</subject><subject>Antineoplastic agents</subject><subject>Antineoplastic Agents - therapeutic use</subject><subject>Azacitidine - adverse effects</subject><subject>Azacitidine - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Chemotherapy</subject><subject>Drug Evaluation</subject><subject>Female</subject><subject>Head and Neck Neoplasms - drug therapy</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Pharmacology. Drug treatments</subject><issn>0167-6997</issn><issn>1573-0646</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1991</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkE1Lw0AQhhdRaq1evAtz8CREZ5NstvGmxWqhoAc9x9mvNtomZTdR6q83kmIPw8C8Dy_Mw9g5x2uOKG_up4h8nIixOGBDLmQSYZZmh2yIPJNRlufymJ2E8IGISS7TARtwGYtuhuz9ZUnBwmwGoWnNFmoHjn7IkyorC2UFZL6o0tbA0pIBqgxUVn-C_jt6uAWCULfN8tuGBupK16t6sYWFr9tN33jKjhytgj3b7RF7mz68Tp6i-fPjbHI3j3QssYlSpXKXEIoEU-1io6RUfGy4dGhcFqPRmKncZpzzsUUiYVOpFO9CKSWSTkbsqu_Vvg7BW1dsfLkmvy04Fn-Wir2lDr7o4U2r1tbs0V5Ll1_ucgqaVs5335bhHxPIhehc_gJqjW5u</recordid><startdate>19911101</startdate><enddate>19911101</enddate><creator>KUEBLER, J. P</creator><creator>METCH, B</creator><creator>SCHULLER, D. E</creator><creator>KEPPEN, M</creator><creator>HYNES, H. E</creator><general>Kluwer</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>19911101</creationdate><title>Phase II study of fazarabine in advanced head and neck cancer : a southwest oncology group study</title><author>KUEBLER, J. P ; METCH, B ; SCHULLER, D. E ; KEPPEN, M ; HYNES, H. E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c270t-4bb9f3a05304cf2db77b18d17f0df620dc06b9e61118e0aa5e47bb10df7770ac3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1991</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Antineoplastic agents</topic><topic>Antineoplastic Agents - therapeutic use</topic><topic>Azacitidine - adverse effects</topic><topic>Azacitidine - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Chemotherapy</topic><topic>Drug Evaluation</topic><topic>Female</topic><topic>Head and Neck Neoplasms - drug therapy</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Pharmacology. Drug treatments</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>KUEBLER, J. P</creatorcontrib><creatorcontrib>METCH, B</creatorcontrib><creatorcontrib>SCHULLER, D. E</creatorcontrib><creatorcontrib>KEPPEN, M</creatorcontrib><creatorcontrib>HYNES, H. E</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Investigational new drugs</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>KUEBLER, J. P</au><au>METCH, B</au><au>SCHULLER, D. E</au><au>KEPPEN, M</au><au>HYNES, H. E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Phase II study of fazarabine in advanced head and neck cancer : a southwest oncology group study</atitle><jtitle>Investigational new drugs</jtitle><addtitle>Invest New Drugs</addtitle><date>1991-11-01</date><risdate>1991</risdate><volume>9</volume><issue>4</issue><spage>373</spage><epage>374</epage><pages>373-374</pages><issn>0167-6997</issn><eissn>1573-0646</eissn><coden>INNDDK</coden><cop>Dordrecht</cop><pub>Kluwer</pub><pmid>1725172</pmid><doi>10.1007/BF00183585</doi><tpages>2</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0167-6997 |
| ispartof | Investigational new drugs, 1991-11, Vol.9 (4), p.373-374 |
| issn | 0167-6997 1573-0646 |
| language | eng |
| recordid | cdi_crossref_primary_10_1007_BF00183585 |
| source | MEDLINE; SpringerNature Journals |
| subjects | Adult Aged Antineoplastic agents Antineoplastic Agents - therapeutic use Azacitidine - adverse effects Azacitidine - therapeutic use Biological and medical sciences Chemotherapy Drug Evaluation Female Head and Neck Neoplasms - drug therapy Humans Male Medical sciences Middle Aged Pharmacology. Drug treatments |
| title | Phase II study of fazarabine in advanced head and neck cancer : a southwest oncology group study |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-03T23%3A08%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Phase%20II%20study%20of%20fazarabine%20in%20advanced%20head%20and%20neck%20cancer%20:%20a%20southwest%20oncology%20group%20study&rft.jtitle=Investigational%20new%20drugs&rft.au=KUEBLER,%20J.%20P&rft.date=1991-11-01&rft.volume=9&rft.issue=4&rft.spage=373&rft.epage=374&rft.pages=373-374&rft.issn=0167-6997&rft.eissn=1573-0646&rft.coden=INNDDK&rft_id=info:doi/10.1007/BF00183585&rft_dat=%3Cpubmed_cross%3E1725172%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/1725172&rfr_iscdi=true |